PAX Financial Group’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,285
Closed -$284K 221
2025
Q3
$284K Sell
23,285
-4,420
-16% -$46.4K 0.05% 188
2025
Q2
$221K Sell
27,705
-10,768
-28% -$75.6K 0.04% 221
2025
Q1
$279K Buy
38,473
+1,840
+5% +$13.4K 0.05% 212
2024
Q4
$252K Buy
36,633
+744
+2% +$5.12K 0.05% 211
2024
Q3
$265K Sell
35,889
-1,263
-3% -$11.8K 0.05% 205
2024
Q2
$392K Buy
37,152
+20,553
+124% +$260K 0.08% 193
2024
Q1
$230K Sell
16,599
-36,549
-69% -$571K 0.05% 209
2023
Q4
$947K Buy
53,148
+39,674
+294% +$732K 0.2% 94
2023
Q3
$286K Buy
13,474
+203
+2% +$5.28K 0.07% 186
2023
Q2
$441K Buy
13,271
+566
+4% +$20.8K 0.1% 169
2023
Q1
$499K Buy
12,705
+906
+8% +$37.7K 0.12% 150
2022
Q4
$497K Buy
11,799
+969
+9% +$37.3K 0.13% 135
2022
Q3
$361K Buy
10,830
+517
+5% +$21.5K 0.09% 150
2022
Q2
$447K Sell
10,313
-960
-9% -$44.1K 0.11% 140
2022
Q1
$540K Buy
11,273
+1,066
+10% +$52.8K 0.13% 129
2021
Q4
$518K Buy
+10,207
New +$454K 0.12% 136

Other funds holding NUS

PAX Financial Group's NUS Position: Q4 2025 in Review

PAX Financial Group sold out of Nu Skin (NUS) in Q4 2025, closing a stake of 23,285 shares — an estimated $284K sold.

PAX Financial Group first reported a position in NUS in Q4 2021 and held it in 16 quarters. The position peaked at $947K in Q4 2023. 187 funds tracked by Wall St. Rank hold NUS as of Q4 2025.

  • PAX Financial Group reported no remaining Nu Skin position as of Q4 2025 after selling out during the quarter.
  • PAX Financial Group sold 23,285 Nu Skin shares in Q4 2025, an estimated $284K.
  • PAX Financial Group first reported a position in Nu Skin in Q4 2021 and held it in 16 quarters.
  • PAX Financial Group's Nu Skin position peaked at $947K in Q4 2023.
  • 187 funds tracked by Wall St. Rank held Nu Skin as of Q4 2025.

Based on PAX Financial Group's 13F filing for Q4 2025, filed 5 Feb 2026.